Medications & Supplements/Prescription Drugs

Ryaltris Nasal Spray Recalled for Clogged Spray Mechanism

Agency Publication Date: October 3, 2024

Summary

Glenmark Pharmaceuticals Inc., USA is recalling 45,504 bottles of Ryaltris (olopatadine hydrochloride and mometasone furoate) Nasal Spray because of a defective delivery system. The dip tube inside the bottle can become clogged, causing the spray mechanism to fail. This recall affects the 29 g bottles containing 240 metered sprays (665 mcg/25 mcg per spray).

Risk

A clogged dip tube prevents the delivery of the medication, which may lead to untreated allergy symptoms. No specific injuries or adverse events were reported in the recall announcement.

What You Should Do

This recall affects Ryaltris (olopatadine hydrochloride and mometasone furoate) Nasal Spray sold in 29 g bottles (240 metered sprays) with NDC 59467-700-27.
Check the lot number and expiration date on your bottle for the following codes: 14230425 (Exp Nov-25), 14240024 (Exp Dec-25), 14240029 (Exp Dec-25), 14240076 (Exp Jan-26), 14240082 (Exp Jan-26), 14240090 (Exp Jan-26), or 14240100 (Exp Jan-26).
If you have health concerns, contact your healthcare provider or pharmacist. Return any unused product to the place of purchase for a refund, throw it away, or contact the manufacturer for further instructions.
Call the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA) for additional questions.

Your Remedy Options

You have 2 options:

Option 1: Full Refund

How to: Contact your healthcare provider or pharmacist for guidance, or return any unused product to the place of purchase for a refund

Option 2: Dispose of Product

How to: Throw the product away. For prescription medications, a DEA take-back location or pharmacy mail-back program is preferred when available.

Affected Products

Product: Ryaltris (olopatadine hydrochloride and mometasone furoate) Nasal Spray (29 g)

Variants: 665 mcg/25 mcg per spray, 240 Metered Sprays/bottle

Lot Numbers:

14230425 (Exp Nov-25)

14240024 (Exp Dec-25)

14240029 (Exp Dec-25)

14240076 (Exp Jan-26)

14240082 (Exp Jan-26)

14240090 (Exp Jan-26)

14240100 (Exp Jan-26)

NDC:

59467-700-27

Distributed by Hikma Specialty USA Inc., Columbus, OH.

Additional Information

Agency: Food and Drug Administration (FDA)

Event ID: 95389

Status: Active

Manufacturer: Glenmark Pharmaceuticals Inc., USA

Sold By: Retail Pharmacies

Manufactured In: United States

Units Affected: 45,504 bottles

Distributed To: Nationwide

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES · Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.

Summary

What You Should Do

This recall affects Ryaltris (olopatadine hydrochloride and mometasone furoate) Nasal Spray sold in 29 g bottles (240 metered sprays) with NDC 59467-700-27.

Check the lot number and expiration date on your bottle for the following codes: 14230425 (Exp Nov-25), 14240024 (Exp Dec-25), 14240029 (Exp Dec-25), 14240076 (Exp Jan-26), 14240082 (Exp Jan-26), 14240090 (Exp Jan-26), or 14240100 (Exp Jan-26).

If you have health concerns, contact your healthcare provider or pharmacist. Return any unused product to the place of purchase for a refund, throw it away, or contact the manufacturer for further instructions.

Call the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA) for additional questions.

Your Remedy Options

You have 2 options:

Option 1: Full Refund

How to: Contact your healthcare provider or pharmacist for guidance, or return any unused product to the place of purchase for a refund

Option 2: Dispose of Product

How to: Throw the product away. For prescription medications, a DEA take-back location or pharmacy mail-back program is preferred when available.

Affected Products

Product: Ryaltris (olopatadine hydrochloride and mometasone furoate) Nasal Spray (29 g)

Variants: 665 mcg/25 mcg per spray, 240 Metered Sprays/bottle

Lot Numbers:

14230425 (Exp Nov-25)

14240024 (Exp Dec-25)

14240029 (Exp Dec-25)

14240076 (Exp Jan-26)

14240082 (Exp Jan-26)

14240090 (Exp Jan-26)

14240100 (Exp Jan-26)

NDC:

59467-700-27

Distributed by Hikma Specialty USA Inc., Columbus, OH.